202 related articles for article (PubMed ID: 7262023)
1. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE
Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023
[No Abstract] [Full Text] [Related]
2. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.
Wenderoth UK; George FW; Wilson JD
Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940
[TBL] [Abstract][Full Text] [Related]
3. Biological activities of a new steroidal inhibitor of delta 4-5 alpha-reductase.
Brooks JR; Berman C; Hichens M; Primka RL; Reynolds GF; Rasmusson GH
Proc Soc Exp Biol Med; 1982 Jan; 169(1):67-73. PubMed ID: 7063497
[No Abstract] [Full Text] [Related]
4. Inhibition of 5 alpha-reductase, receptor binding, and nuclear uptake of androgens in the prostate by a 4-methyl-4-aza-steroid.
Liang T; Heiss CE
J Biol Chem; 1981 Aug; 256(15):7998-8005. PubMed ID: 7263637
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
6. Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5 alpha-reductase.
Kadohama N; Wakisaka M; Kim U; Karr JP; Murphy GP; Sandberg AA
J Natl Cancer Inst; 1985 Feb; 74(2):475-86. PubMed ID: 3856054
[TBL] [Abstract][Full Text] [Related]
7. 12. Androgens: Pharmacodynamics and antagonists. Biochemical and biological studies with 4-aza-steroidal 5 alpha-reductase inhibitors.
Liang T; Rasmusson GH; Brooks JR
J Steroid Biochem; 1983 Jul; 19(1A):385-90. PubMed ID: 6887871
[TBL] [Abstract][Full Text] [Related]
8. Effect of a new 5 alpha-reductase inhibitor on size, histologic characteristics, and androgen concentrations of the canine prostate.
Brooks JR; Berman D; Glitzer MS; Gordon LR; Primka RL; Reynolds GF; Rasmusson GH
Prostate; 1982; 3(1):35-44. PubMed ID: 7079196
[TBL] [Abstract][Full Text] [Related]
9. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
Zaccheo T; Giudici D; Panzeri A; di Salle E
Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
[TBL] [Abstract][Full Text] [Related]
10. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
Martel C; Trudel C; Couet J; Labrie C; BĂ©langer A; Labrie F
Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of 5 alpha-reductase activity and alteration of nuclear testosterone. Dihydrotestosterone ratio in human genital skin fibroblasts.
Berkovitz GD; Brown TR; Migeon CJ
J Androl; 1984; 5(3):171-5. PubMed ID: 6746410
[TBL] [Abstract][Full Text] [Related]
12. 4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor.
Liang T; Heiss CE; Cheung AH; Reynolds GF; Rasmusson GH
J Biol Chem; 1984 Jan; 259(2):734-9. PubMed ID: 6693392
[TBL] [Abstract][Full Text] [Related]
13. 5 Alpha-reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat.
Brooks JR; Berman C; Primka RL; Reynolds GF; Rasmusson GH
Steroids; 1986 Jan; 47(1):1-19. PubMed ID: 3810695
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of prostatic tumor 5 alpha-reductase by a 4-methyl-4-azasteroid.
Kadohama N; Karr JP; Murphy GP; Sandberg AA
Cancer Res; 1984 Nov; 44(11):4947-54. PubMed ID: 6488158
[TBL] [Abstract][Full Text] [Related]
15. Effects of an anti-androgen and 5 alpha-reductase inhibitors on estrus duration in the cycling female rat.
Erskine MS
Physiol Behav; 1983 Apr; 30(4):519-24. PubMed ID: 6683842
[TBL] [Abstract][Full Text] [Related]
16. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
Fleshner NE; Trachtenberg J
J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of steroid 5 alpha-reductase from human skin fibroblasts by 17 beta-N,N-diethylcarbamoyl-4-methyl-4-aza-5 alpha-androstan-3-one.
Leshin M; Wilson JD
J Steroid Biochem; 1982 Sep; 17(3):245-50. PubMed ID: 6957692
[TBL] [Abstract][Full Text] [Related]
18. Combination of an antiandrogen and a 5 alpha-reductase inhibitor: a further step towards total androgen blockade?
Labrie C; Trudel C; Li S; Martel C; CouĂȘt J; Labrie F
Endocrinology; 1991 Jul; 129(1):566-8. PubMed ID: 2055205
[TBL] [Abstract][Full Text] [Related]
19. Effect of a 4-methyl-4-aza steroid on androgen metabolism by rat ventral prostate epithelial and stromal cell cultures: selective inhibition of 5 alpha-reductase activity.
Orlowski J; Clark AF
Prostate; 1988; 13(4):289-97. PubMed ID: 3217276
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of 3 beta HSD activity in porcine granulosa cells by 4-MA, a potent 5 alpha-reductase inhibitor.
Chan WK; Fong CY; Tiong HH; Tan CH
Biochem Biophys Res Commun; 1987 Apr; 144(1):166-71. PubMed ID: 3107552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]